vimarsana.com

Page 12 - Binding Affinity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A non-covalent inhibitor of 3C-like protease effectively inhibits SARS-CoV-2 replication

Researchers assessed highly potent non-covalent inhibitors of SARS-CoV-2 3CLpro.

Cristian moga shutterstockImage creditMiddle eastCoronavirus disease covid 19Ars cov 2Binding affinityCovid 19Magnetic beadsErs covEvere acute respiratoryEvere acute respiratory syndrome

Bispecific antibody exhibits high breadth and potency against SARS-CoV-2 Omicron sub-lineages

In a new study, researchers developed bispecific-antibodies (bsAbs) against SARS-CoV-2 Omicron sub-lineages.

South africaBispecific antibodyCoronavirus disease covid 19Ars cov 2Binding affinityCovid 19Evere acute respiratoryEvere acute respiratory syndromeSpike protein

Mechanistic insights into engineered ACE2 receptor traps

Researchers determined the cryo-electron microscopic (cryo-EM) structures of engineered angiotensin-converting enzyme 2 (ACE2) receptor traps.

Kateryna kon shutterstockCoronavirus disease covid 19Ngiotensin converting enzyme 2Binding affinityCovid 19Ars cov 2Evere acute respiratoryEvere acute respiratory syndromeSpike protein

The features of the newly emerging SARS-CoV-2 Omicron BA 2 75 subvariant

Researchers evaluated all the features, especially the antigenic properties and transmission potential of SARS-CoV-2 Omicron sub-variant BA.2.75.

Coronavirus disease covid 19Ars cov 2Binding affinityN vitroPublic healthEvere acute respiratoryEvere acute respiratory syndrome

Hemopurifier containing Galanthus nivalis resin removes SARS-CoV-2 variants

Scientists hypothesize that the GNA affinity resin would remain effective against SARS-CoV-2 variants.

Lifecollectionphotography shutterstockAethlon hemopurifierDelta plusAntiviral drugCoronavirus disease covid 19Ars cov 2Binding affinityCovid 19N vitroN vivoEvere acute respiratoryEvere acute respiratory syndromeSpike protein

vimarsana © 2020. All Rights Reserved.